Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Avantis's Series C brings in $10mm

Executive Summary

Avantis Medical Systems (endoscopic devices for GI cancer detection) raised $10mm through its Series C financing round. MC Silicon Valley (the venture investment firm of Mitsubishi International) led and was joined by returning backers including Montreux Equity Partners, Thomas Fogarty, MD, and CN Investment Partners. The company will use the proceeds to establish Centers of Excellence to expedite the launch of its Third Eye Retroscope colon lesion detection device. Mitsubishi will take a seat on Avantis's board.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register